Practical management of Raynaud's phenomenon - a primer for practicing physicians

Area of Science:

• Vascular Medicine
• Rheumatology
• Clinical Practice Guidelines

Background:

• Raynaud's phenomenon (RP) is a prevalent vasospastic disorder causing digital hypoperfusion due to cold or emotional triggers.
• RP is linked to substantial pain and functional disability, impacting patients' quality of life.
• Identifying patients at risk for progression to systemic sclerosis (SSc) is crucial for early intervention.

Purpose of the Study:

• To offer clinicians a practical, evidence-based framework for assessing and managing Raynaud's phenomenon.
• To guide therapeutic strategies, including drug selection, escalation, and potential surgical interventions.
• To synthesize recent findings on risk stratification and patient experience in RP management.

Main Methods:

• Review of current literature and clinical guidelines on Raynaud's phenomenon assessment and treatment.
• Analysis of key investigations such as autoantibodies and nailfold capillaroscopy for risk stratification.
• Incorporation of findings from multicenter studies like the very early diagnosis of systemic sclerosis (VEDOSS) project.

Main Results:

• Autoantibodies and nailfold capillaroscopy are vital for stratifying RP patients' risk of developing systemic sclerosis.
• Calcium channel blockers are recommended as the first-line pharmacological treatment for RP.
• Second-line therapies and surgical interventions are considered for refractory cases of Raynaud's phenomenon.

Conclusions:

• A structured clinical approach enhances the assessment and management of patients with Raynaud's phenomenon.
• Timely initiation and escalation of appropriate medical therapies, starting with calcium channel blockers, are key.
• Further research into outcome measures and international treatment variations is warranted for optimizing RP care.